Involvement of 5-HT2A receptors in the serotonin (5-HT) syndrome caused by excessive 5-HT efflux in rat brain. 2010

Swapna Krishnamoorthy, and Zhiyuan Ma, and Gongliang Zhang, and Jianning Wei, and Sidney B Auerbach, and Rui Tao
Charles E. Schmidt College of Biomedical Science, Florida Atlantic University, Boca Raton, FL, USA.

Previous studies have demonstrated that serotonin (5-HT) syndromes, particularly for the malignant cases, can be alleviated by ice water mists, cooling blankets and many other external cooling measures. In this study, we tested the hypothesis that external cooling measures reduce the responsivity of 5-HT(2A) receptors to excessive 5-HT efflux, which may be a possible mechanism underlying the treatment of serotonin syndrome. To test this, rat experiments were carried out in the standard and cool ambient temperature (T(amb) ) by administration of the 5-HT precursor 5-hydroxy-L-tryptophan combined with the monoamine oxidase inhibitor clorgyline. The first set of experiments was to assess severity of the syndromes by measuring body temperature responses. Consistent with the hypothesis, we found that the syndrome was malignant at the standard T(amb) of 22°C but alleviated at 12 or 6°C, these results being similar to those in rats pre-treated with the 5-HT(2A) receptor antagonist ketanserin. The second set of experiments was to utilize microdialysis to determine the relationship between the syndrome severity and 5-HT levels at the above-mentioned T(amb) . We found that excessive 5-HT efflux consisted of primary and secondary components through two distinct mechanisms. Furthermore, the secondary component efflux, which can be ascribed to 5-HT(2A) receptor activation, was proportionally reduced at the cool T(amb) of 12 and 6°C. In conclusion, results of this study support the hypothesis that cooling T(amb) reduces the functional activity of 5-HT(2A) receptors, thus alleviating the malignant syndrome.

UI MeSH Term Description Entries
D007036 Hypothermia, Induced Abnormally low BODY TEMPERATURE that is intentionally induced in warm-blooded animals by artificial means. In humans, mild or moderate hypothermia has been used to reduce tissue damages, particularly after cardiac or spinal cord injuries and during subsequent surgeries. Induced Hypothermia,Mild Hypothermia, Induced,Moderate Hypothermia, Induced,Targeted Temperature Management,Therapeutic Hypothermia,Hypothermia, Therapeutic,Induced Mild Hypothermia,Induced Mild Hypothermias,Induced Moderate Hypothermia,Induced Moderate Hypothermias,Mild Hypothermias, Induced,Moderate Hypothermias, Induced,Targeted Temperature Managements
D007650 Ketanserin A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione,R-41,468,R-41468,R 41,468,R 41468,R41,468,R41468
D008297 Male Males
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D001831 Body Temperature The measure of the level of heat of a human or animal. Organ Temperature,Body Temperatures,Organ Temperatures,Temperature, Body,Temperature, Organ,Temperatures, Body,Temperatures, Organ
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003010 Clorgyline An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE. Clorgilin,Chlorgyline,Clorgiline
D006916 5-Hydroxytryptophan The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant. 5-HTP,Hydroxytryptophan,Oxitriptan,Oxytryptophan,Tryptophan, 5-Hydroxy-,5 Hydroxytryptophan,5-Hydroxy- Tryptophan,Tryptophan, 5 Hydroxy
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012701 Serotonin A biochemical messenger and regulator, synthesized from the essential amino acid L-TRYPTOPHAN. In humans it is found primarily in the central nervous system, gastrointestinal tract, and blood platelets. Serotonin mediates several important physiological functions including neurotransmission, gastrointestinal motility, hemostasis, and cardiovascular integrity. Multiple receptor families (RECEPTORS, SEROTONIN) explain the broad physiological actions and distribution of this biochemical mediator. 5-HT,5-Hydroxytryptamine,3-(2-Aminoethyl)-1H-indol-5-ol,Enteramine,Hippophaine,Hydroxytryptamine,5 Hydroxytryptamine

Related Publications

Swapna Krishnamoorthy, and Zhiyuan Ma, and Gongliang Zhang, and Jianning Wei, and Sidney B Auerbach, and Rui Tao
January 2017, PloS one,
Swapna Krishnamoorthy, and Zhiyuan Ma, and Gongliang Zhang, and Jianning Wei, and Sidney B Auerbach, and Rui Tao
March 2000, Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova,
Swapna Krishnamoorthy, and Zhiyuan Ma, and Gongliang Zhang, and Jianning Wei, and Sidney B Auerbach, and Rui Tao
March 2014, BMJ (Clinical research ed.),
Swapna Krishnamoorthy, and Zhiyuan Ma, and Gongliang Zhang, and Jianning Wei, and Sidney B Auerbach, and Rui Tao
September 2011, Neuropharmacology,
Swapna Krishnamoorthy, and Zhiyuan Ma, and Gongliang Zhang, and Jianning Wei, and Sidney B Auerbach, and Rui Tao
September 1992, Progress in neuro-psychopharmacology & biological psychiatry,
Swapna Krishnamoorthy, and Zhiyuan Ma, and Gongliang Zhang, and Jianning Wei, and Sidney B Auerbach, and Rui Tao
January 1999, Journal of psychiatric research,
Swapna Krishnamoorthy, and Zhiyuan Ma, and Gongliang Zhang, and Jianning Wei, and Sidney B Auerbach, and Rui Tao
May 2016, Biochemical and biophysical research communications,
Swapna Krishnamoorthy, and Zhiyuan Ma, and Gongliang Zhang, and Jianning Wei, and Sidney B Auerbach, and Rui Tao
January 2012, Molekuliarnaia biologiia,
Swapna Krishnamoorthy, and Zhiyuan Ma, and Gongliang Zhang, and Jianning Wei, and Sidney B Auerbach, and Rui Tao
April 2009, Journal of molecular and cellular cardiology,
Swapna Krishnamoorthy, and Zhiyuan Ma, and Gongliang Zhang, and Jianning Wei, and Sidney B Auerbach, and Rui Tao
October 2013, Experimental brain research,
Copied contents to your clipboard!